The discrepancy between the previously reported observation in cells of reduced DEPTOR binding to activated cancer-associated mutants (Grabiner et al., 2014) and our observation of a lowered DEPTOR IC50 and increased affinity in our reconstituted system for activated mTORC1 might be explained by upregulated cellular processes in cancer cells. This evidence concerns the gene DEPTOR and cancer.